..
It’s not Ivermectin but molnupiravir.
..
Molnupiravir is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication. Wikipedia
..
FDA AMDAC has voted 13 yes, 10 no for EUA for Merck's molnupiravir COVID-19 drug. I voted no. Inclusive data on mutagenic potential and concerns over generating troublesome SARS-CoV2 variants were not addressed to my satisfaction. Drug has modest 30% reduction in COVID-19 risk.
— James E.K. Hildreth (@JamesEKHildreth) November 30, 2021
..
Wow! Great news on an oral anti-viral drug for COVID19 treatment!! https://t.co/82HTFvoERK
— Dr. Catherine Kyobutungi #Covid19Vaccinated (@CKyobutungi) October 1, 2021
..
“This is the first oral antiviral that will be available to combat COVID-19,” Merck CEO and president tells @GMA as preliminary results claim new COVID-19 pills may keep recently diagnosed patients out of hospital. https://t.co/H3Z0YdcK9N pic.twitter.com/eNVVQBdblc
— ABC News (@ABC) October 1, 2021
..
Merck says its Covid-19 pill cuts hospitalization and deaths by half. The pharmaceutical company plans to seek FDA emergency use authorization next. It would become the first oral antiviral for Covid-19 if approved. https://t.co/K2RCOmOZRo pic.twitter.com/AdkZ8Fd1o5
— CNN Breaking News (@cnnbrk) October 1, 2021
..
Merck has a Covid-19 pill but it's not Ivermctin. https://t.co/2RKYpQhg6M
— KittyPooh (@KittyPo80176717) September 30, 2021
..
https://t.co/111LvOvKy1
— Maureen Reed (@MaureenReed11) September 30, 2021
Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coro…
..
Laboratory studies show that Merck & Co's experimental oral #COVID19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible #Delta.
— The Jerusalem Post (@Jerusalem_Post) September 29, 2021
⤵️⤵️https://t.co/gVPV9bMA5b
..
..
..
weehingthong
Pingback: The attack on Big Pharma continues: The agenda is to take down Merck, “classic Big Pharma” | weehingthong